Search Within

Gabriella D'Andrea-Carlino

Formats
  1. Meeting Abstract (41)
  2. Journal Article (37)
Groups
  1. Breast Medicine Service (78)
  2. Department of Medicine (78)
  3. Solid Tumor Oncology Division (78)
  4. Survivorship Research (78)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (56)
  6. Epidemiology and Biostatistics (55)

More Groups

People
  1. Clifford Hudis (64)
  2. Larry Norton (45)
  3. Diana Lake (39)
  4. Monica Fornier (38)
  5. Andrew Seidman (36)
  6. Chau Dang (33)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2018 (3)
  5. 2017 (2)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Cancer Research (11)
  3. Breast Cancer Research and Treatment (9)
  4. Clinical Cancer Research (9)
  5. Clinical Breast Cancer (8)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (10)
  4. Springer (10)
  5. Oxford University Press (4)
  6. Wiley Blackwell (4)

More Publishers

Results (78)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Increased dose density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C.; Panageas, K. S.; Atienza, M.; Norton, L.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
    Journal Article

    Deng, G.; Vickers, A.; Yeung, S.; D'Andrea, G.; Xiao, H.; Heerdt, A.; Sugarman, S.; Troso-Sandoval, T.; Seidman, A.; Hudis, C.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
    Meeting Abstract

    Hurria, A.; Goldfarb, S.; Rosen, C.; Holland, J.; Zuckerman, E.; Lachs, M.; Witmer, M.; van Gorp, W.; Fornier, M.; D'Andrea, G.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Norton, L.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
    Journal Article

    Modi, S.; D'Andrea, G.; Norton, L.; Yao, T. J.; Caravelli, J.; Rosen, P. P.; Hudis, C.; Seidman, A. D.
    Clinical Breast Cancer (2006)

    Fulltext@MSK | Save
  • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Zuckerman, E.; Panageas, K. S.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save